Form 4: Director Monica Reed Increases Stake in Intuitive Surgical

Intuitive Surgical Director Monica Reed acquired 554 restricted stock units and converted 531 units into common stock as part of her annual compensation.

Summary

• Director Monica P. Reed executed two transactions involving equity securities on April 30, 2026.
• Reed converted 531 Restricted Stock Units (RSUs) into an equivalent number of common stock shares at a conversion price of $0.00.
• A new grant of 554 RSUs was awarded to Reed, which will vest fully on the earlier of the one-year anniversary or the next Annual Meeting of Stockholders.
• Following these transactions, Reed directly owns 2,876 shares of Intuitive Surgical common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing. While insider accumulation is generally positive, this specific transaction is part of a pre-determined compensation structure rather than an open-market purchase.

Positives

• Director maintains a growing equity position in the company, aligning interests with shareholders.
• The acquisition of 554 new RSUs indicates continued commitment to the board of directors.
• The conversion of 531 RSUs into common stock increases the director's direct ownership of voting shares.

Negatives

• No significant negative factors identified; this is a routine administrative filing for director compensation.

Risks

• Vesting of the newly granted 554 RSUs is subject to the reporting person's continued service through the vesting date.

Future Outlook

The 554 newly granted RSUs are scheduled to vest on the earlier of April 30, 2027, or the date of the next Annual Meeting of Stockholders, provided the director remains in service.

Management Comments

• 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is a standard practice in the healthcare and medical technology sectors to ensure board members are incentivized to drive long-term shareholder value.

Comparison to Industry Standards

• The grant size and vesting schedule are consistent with director compensation packages at other large-cap medical device companies such as Medtronic and Stryker.
• The use of RSUs rather than stock options reflects a broader industry trend toward full-value equity awards for non-employee directors.

Related Party Transactions

• The reporting person received an equity grant of 554 RSUs as part of her role as a Director of the company.

Stakeholder Impact

• Shareholders may view the director's increased equity stake as a sign of alignment with long-term company performance.

Next Steps

• Vesting of 554 RSUs on or before April 30, 2027.

Key Dates

Keywords

Intuitive Surgical, ISRG, Insider Trading, Form 4, Director Compensation, Restricted Stock Units, Monica Reed, Medical Devices